$6.61
2.65% yesterday
Nasdaq, Nov 25, 10:01 pm CET
ISIN
US7458481014
Symbol
LUNG

ProLung Inc Stock price

$6.61
+0.58 9.62% 1M
-1.46 18.09% 6M
-6.14 48.16% YTD
-4.48 40.40% 1Y
-27.91 80.85% 3Y
-12.39 65.21% 5Y
-12.39 65.21% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.18 2.65%
ISIN
US7458481014
Symbol
LUNG
Sector

Key metrics

Market capitalization $261.02m
Enterprise Value $208.79m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.63
P/S ratio (TTM) P/S ratio 3.29
P/B ratio (TTM) P/B ratio 2.78
Revenue growth (TTM) Revenue growth 22.34%
Revenue (TTM) Revenue $79.30m
EBIT (operating result TTM) EBIT $-56.49m
Free Cash Flow (TTM) Free Cash Flow $-34.79m
Cash position $108.04m
EPS (TTM) EPS $-1.47
P/E forward negative
P/S forward 3.17
EV/Sales forward 2.54
Short interest 3.54%
Show more

Is ProLung Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

ProLung Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a ProLung Inc forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a ProLung Inc forecast:

Buy
83%
Hold
17%

Financial data from ProLung Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
79 79
22% 22%
100%
- Direct Costs 21 21
20% 20%
26%
59 59
23% 23%
74%
- Selling and Administrative Expenses 98 98
10% 10%
123%
- Research and Development Expense 16 16
13% 13%
20%
-55 -55
7% 7%
-69%
- Depreciation and Amortization 1.69 1.69
52% 52%
2%
EBIT (Operating Income) EBIT -56 -56
10% 10%
-71%
Net Profit -57 -57
7% 7%
-72%

In millions USD.

Don't miss a Thing! We will send you all news about ProLung Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ProLung Inc Stock News

Neutral
GlobeNewsWire
6 days ago
REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference in New York on Wednesday, December 4, 2024, at 9:30 AM PT / 12:30 PM ET.
Neutral
Business Wire
7 days ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, and the American Lung Association are continuing their ongoing collaboration with two new programs aimed at supporting patients with severe COPD and emphysema. Building on their successful partnership, the two organizations will launch ...
Neutral
GlobeNewsWire
21 days ago
REDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Stifel 2024 Healthcare Conference in New York on Tuesday, November 19, 2024, at 6:10 AM PT / 9:10 AM ET.
More ProLung Inc News

Company Profile

Pulmonx Corp. provides interventional pulmonology, planning tools, and treatments for obstructive lung diseases. It carries out its operations in the following geographical locations: Europe, Middle East and Africa (EMEA), Asia Pacific, Other International, and United States. It offers the Zephyr Endobronchial Valve, an implantable device used to occlude all airways feeding the hyperinflated lobe of a lung that is most diseased with emphysema. It also offers StratX Lung Analysis, a platform designed to treat severe emphysema, and the Chartis Assessment System, a pulmonary assessment system. The company was founded by Rodney C. Perkins and is headquartered in Redwood City, CA.

Head office United States
CEO Steven Williamson
Employees 279
Founded 1995
Website www.pulmonx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today